TP53 and colonic neoplasm: In the colon cancer cell line HCT116 with wild-type p53, treatment with oxaliplatin induced AKR1B10 gene expression significantly more than other chemotherapeutic agents, while in the colon cancer cell line HT29 with mutated p53, it had a significant effect but in the opposite direction [60].